Preventing Schizophrenia and Alzheimer Disease: Comparative Ethics
Overview
Authors
Affiliations
Schizophrenia and Alzheimer disease are both diseases of the brain that involve genetic susceptibility factors and for which the prevention or delay of symptom onset are important research goals. This paper provides some comparisons between current preventive efforts in schizophrenia and Alzheimer disease, focusing on certain ethical features of these endeavors such as potential discrimination, misdiagnosis, and stigma.
Fekih-Romdhane F, Loch A, Hallit S Front Psychiatry. 2024; 15:1486496.
PMID: 39310663 PMC: 11412815. DOI: 10.3389/fpsyt.2024.1486496.
Kim S, Kim J, Han J, Jhon M, Kim J, Lee J Psychiatry Investig. 2020; 17(4):306-311.
PMID: 32200606 PMC: 7176566. DOI: 10.30773/pi.2019.0215.
Kim S, Chung Y, Kang Y, Kim J, Jang J, Jhon M Psychiatry Investig. 2018; 15(2):111-117.
PMID: 29475231 PMC: 5900395. DOI: 10.30773/pi.2017.04.24.
After the revolution? Ethical and social challenges in 'personalized genomic medicine'.
Juengst E, Settersten Jr R, Fishman J, McGowan M Per Med. 2013; 9(4):429-439.
PMID: 23662108 PMC: 3646379. DOI: 10.2217/pme.12.37.
Self-report of attenuated psychotic experiences in a college population.
Loewy R, Johnson J, Cannon T Schizophr Res. 2007; 93(1-3):144-51.
PMID: 17459662 PMC: 2063995. DOI: 10.1016/j.schres.2007.02.010.